Given Imaging (GIVN) Stock Price, News & Analysis

Company Overview

Given Imaging Ltd (Given) develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. It is engaged in capsule endoscopy, which is an approach to visual examination of the gastrointestinal tract through the use of a miniaturized video camera contained in an ingestible disposable capsule. Its principal product, which incorporates its core technology, is the Given System, a wireless imaging system that uses its disposable video capsules, the PillCam capsules. The PillCam capsules can be easily ingested by patients and move naturally through the gastrointestinal tract while wirelessly transmitting to a portable recorder, enabling the gastroenterologist to view video, images and data on a computer workstation, utilizing its RAPID software. In October 2012, it acquired the assets related to the SmartPill GI Monitoring System from The SmartPill Corporation.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GIVN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Given Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Given Imaging investors own include Cray (CRAY), Mazor Robotics (MZOR), Minerva Neurosciences (NERV), Snap (SNAP), Teva Pharmaceutical Industries (TEVA), AXT (AXTI) and AudioCodes (AUDC).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GIVN
• CIK: 1126140
• Web: N/A
• Phone: +972-4-9097777
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A